No Matches Found


Loading...
{{stock_short.stock.stock_name.value}}
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
{{ra.field}}
{{ra.stock_return.chgp}}%
{{ra.sensex_return.chgp}}%
{{stock_short.result_details[0].header}}
{{stock_short.result_details[0].latest.to_period}}
{{stock_short.result_details[0].latest.from_period}}
Change%
{{latest.field}}
{{latest.to}}{{latest.value_suffix}}
{{latest.from}}{{latest.value_suffix}}
{{latest.per}}
Figures in Rs cr

Extendicare's Financial Metrics Highlight Strong Management Amid Slower Long-Term Growth

Extendicare, Inc. has recently experienced a change in evaluation, reflecting shifts in its financial metrics and market position. The company boasts a strong return on capital employed and is net-debt free, enhancing its financial stability. It has shown consistent positive performance over the last 11 quarters, despite slower long-term growth.

Jul 06 2026 03:24 PM IST
share
Share Via
Extendicare's Financial Metrics Highlight Strong Management Amid Slower Long-Term Growth

Extendicare's Financial Metrics Show Positive Trends Amid Strong Profit Growth

Extendicare, Inc. has recently experienced a score adjustment reflecting significant changes in its financial metrics. The company shows improved technical indicators, strong management efficiency, and impressive net profit growth. Its valuation has shifted, highlighting a robust performance and favorable market position amidst a net-debt-free status.

Jun 25 2026 03:18 PM IST
share
Share Via
Extendicare's Financial Metrics Show Positive Trends Amid Strong Profit Growth

Extendicare's Valuation Shift Reflects Changes in Financial Health and Market Perception

Extendicare, Inc. has experienced a change in its valuation grade, reflecting shifts in its financial metrics. Key indicators include a P/E ratio of 25 and a price-to-book value of 6.84, suggesting a premium valuation. The company shows strong management efficiency but faces challenges with high debt levels and modest growth rates.

Jun 08 2026 03:16 PM IST
share
Share Via
Extendicare's Valuation Shift Reflects Changes in Financial Health and Market Perception

Extendicare, Inc. Hits Day High with 10.06% Surge in Stock Price

Extendicare, Inc. has shown notable stock performance, with significant gains over various time frames, including a 128.55% increase over the past year. The company has maintained positive results for six consecutive quarters, demonstrating strong management efficiency and a solid market position in the hospital industry.

Mar 02 2026 05:48 PM IST
share
Share Via
Extendicare, Inc. Hits Day High with 10.06% Surge in Stock Price

Extendicare Adjusts Evaluation Amid Strong Management Efficiency and Debt Concerns

Extendicare, Inc. has recently experienced a change in its evaluation, reflecting its performance metrics and market position. The company shows strong management efficiency and has achieved notable growth in net sales and operating profit over five years, despite reporting flat financial performance for the latest quarter.

Feb 10 2026 03:12 PM IST
share
Share Via
Extendicare Adjusts Evaluation Amid Strong Management Efficiency and Debt Concerns

Extendicare Adjusts Valuation Metrics Amid Strong Operational Performance and Growth Potential

Extendicare, Inc. has recently adjusted its valuation metrics, reflecting a change in its financial standing. Key indicators include a P/E ratio of 14 and a Price to Book Value of 8.89, alongside strong operational efficiency metrics. The company has achieved a notable return over the past year and reported positive results for six consecutive quarters.

Sep 03 2025 04:43 PM IST
share
Share Via
Extendicare Adjusts Valuation Metrics Amid Strong Operational Performance and Growth Potential

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via
{{list.post_title_sep}}

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read